Lena Uller
Lena Uller
Scattering and lmaging for Health lnsights and New Evidence Core Group member and leader of WG2 (Airway diseases), LINXS Fellow
Professor, Lund University, Lund, Sweden
Prof. Uller is head of the research group Respiratory lmmunopharmacology at BMC, Lund with a clear translational research focus on airway diseases such as asthma and COPD as well as allergic rhinitis. The Uller team originally discovered an overproduction of the cytokine TSLP in the bronchial epithelium in patients with asthma and COPD that paved the way for a new personalized biological treatment for severe asthma. The Uller team studies the role of airway epithelium, the first line of defense, in airway diseases but also investigates how the epithelium initiates, orchestrates and shapes local and systemic inflammation in airway diseases. Furthermore, the team discovered an increased epithelial hyperreactivity to inhaled agents such as rhinovirus allergen and PM2.5 and now want to address how the epithelial barrier structure is influenced using integrative approaches by combining the use of X-rays and electrons.
